# VRTX (Vertex Pharmaceuticals Inc. / Ma) - SEC EDGAR Financial Statements

> Vertex Pharmaceuticals Inc. / Ma reported $12.95B in revenue and net income of $3.98B for the trailing twelve months ended September 30, 2026 (up 11.8% year over year), with a 85.5% gross margin and a 33.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/VRTX
- Markdown: https://convexityos.com/fundamentals/VRTX.md
- SEC CIK: 0000875320
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:01 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000875320&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $12.95B | +11.8% YoY |
| Operating Income | TTM | $4.30B | 33.2% margin |
| Net Income | TTM | $3.98B | 30.7% net margin |
| Diluted EPS | TTM | $15.58 | Split-adjusted |
| Free Cash Flow | TTM | $3.20B | 24.7% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $6.30B | Total debt: $6.48B |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $12.00B | $11.02B | $9.87B | $8.93B | $7.57B | $6.21B | $4.16B | $3.05B | $2.49B | $1.70B |
| Cost of Revenue | $1.65B | $1.53B | $1.26B | $1.08B | $904.2M | $736.3M | $547.8M | $409.5M | $275.1M | $210.5M |
| **Gross Profit** | $10.35B | $9.49B | $8.61B | $7.85B | $6.67B | $5.47B | $3.62B | $2.64B | $2.21B | $1.49B |
| Research & Development | $3.91B | $3.63B | $3.16B | $2.54B | $3.05B | $1.83B | $1.75B | $1.42B | $1.32B | $1.05B |
| Selling, General & Admin | $1.75B | $1.46B | $1.14B | $944.7M | $840.1M | $770.5M | $658.5M | $557.6M | $496.1M | $432.8M |
| **Operating Income** | $4.17B | -$232.9M | $3.83B | $4.31B | $2.78B | $2.86B | $1.20B | $635.1M | $123.2M | $9.94M |
| **EBITDA** | $4.38B | -$25.70M | $4.01B | $4.46B | $2.91B | $2.97B | $1.30B | $707.6M | $184.6M | $71.33M |
| Interest Income | $490.9M | $598.1M | $614.7M | $144.6M | $4.90M | $22.20M | $63.70M | $38.35M | $11.75M | -- |
| Interest Expense | $13.30M | $30.60M | $44.10M | $54.80M | -- | $58.15M | $58.50M | $72.47M | $69.30M | -- |
| Income Before Tax | $4.64B | $248.5M | $4.38B | $4.23B | $2.73B | $3.12B | $1.39B | $600.2M | -$15.69M | -$67.37M |
| Income Tax Expense | $690.0M | $784.1M | $760.2M | $910.4M | $388.3M | $405.2M | $218.1M | -$1.49B | -$107.3M | $16.66M |
| **Net Income** | $3.95B | -$535.6M | $3.62B | $3.32B | $2.34B | $2.71B | $1.18B | $2.10B | $263.5M | -$112.1M |
| Basic EPS | $15.46 | -$2.08 | $14.05 | $12.97 | $9.09 | $10.44 | $4.58 | $8.24 | $1.06 | -$0.46 |
| **Diluted EPS** | $15.32 | -$2.08 | $13.89 | $12.82 | $9.01 | $10.29 | $4.51 | $8.09 | $1.04 | -$0.46 |
| Basic Shares Outstanding | 255.7M | 257.9M | 257.7M | 256.1M | 257.7M | 259.8M | 256.7M | 254.3M | 248.9M | 244.7M |
| Diluted Shares Outstanding | 258.0M | 257.9M | 260.5M | 259.1M | 259.9M | 263.4M | 260.7M | 259.2M | 253.2M | 244.7M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $3.44B | $3.33B | $2.99B | $3.19B | $3.08B | $2.96B | $2.77B | $2.91B |
| Cost of Revenue | $526.1M | $489.2M | $392.8M | $466.0M | $414.8M | $407.5M | $363.0M | $423.4M |
| **Gross Profit** | $2.91B | $2.84B | $2.59B | $2.72B | $2.66B | $2.56B | $2.41B | $2.49B |
| Research & Development | $1.32B | $993.8M | $961.6M | $973.7M | $977.7M | $978.4M | $979.7M | $998.7M |
| Selling, General & Admin | $844.1M | $582.2M | $493.7M | $487.0M | $445.1M | $424.6M | $396.4M | $377.6M |
| **Operating Income** | $712.9M | $1.25B | $1.14B | $1.21B | $1.19B | $1.15B | $630.1M | $1.03B |
| **EBITDA** | $782.1M | $1.30B | $1.19B | $1.26B | $1.24B | $1.20B | $678.5M | $1.07B |
| Interest Income | $118.4M | -- | -- | $121.9M | $125.7M | $122.4M | $120.9M | $128.2M |
| Interest Expense | $36.00M | -- | -- | $3.30M | $3.30M | $3.70M | $3.00M | $2.80M |
| Income Before Tax | $783.4M | $1.39B | $1.25B | $1.33B | $1.30B | $1.28B | $730.4M | $1.14B |
| Income Tax Expense | $129.8M | $292.0M | $221.5M | $139.9M | $215.9M | $250.1M | $84.10M | $223.5M |
| **Net Income** | $653.6M | $1.10B | $1.03B | $1.19B | $1.08B | $1.03B | $646.3M | $913.0M |
| Basic EPS | $2.58 | $4.34 | $4.06 | -- | $4.24 | $4.02 | $2.52 | -- |
| **Diluted EPS** | $2.56 | $4.31 | $4.02 | -- | $4.20 | $3.99 | $2.49 | -- |
| Basic Shares Outstanding | 253.5M | 253.7M | 254.1M | -- | 255.6M | 256.7M | 256.9M | -- |
| Diluted Shares Outstanding | 255.2M | 255.2M | 256.3M | -- | 257.6M | 258.9M | 259.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2019 | FY 2018 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.08B | $4.57B | $10.37B | $10.50B | $6.79B | $5.99B | $3.11B | -- | $2.65B | -- |
| Short-Term Investments | $1.52B | $1.55B | $849.2M | $274.5M | $729.9M | $670.7M | $699.0M | -- | $518.1M | -- |
| **Cash & Short-Term Investments** | $6.61B | $6.12B | $11.22B | $10.78B | $7.52B | $6.66B | $3.81B | -- | $3.17B | -- |
| Accounts Receivable, Net | $2.05B | $1.61B | $1.56B | $1.44B | $1.14B | $885.4M | $633.5M | -- | $409.7M | $311.2M |
| Inventory | $1.69B | $1.21B | $738.8M | $460.6M | $353.1M | $280.8M | $167.5M | -- | $124.4M | $111.7M |
| Other Current Assets | $110.9M | $76.40M | $84.30M | $74.40M | $59.20M | $79.70M | -- | -- | $61.59M | -- |
| **Total Current Assets** | $11.20B | $9.60B | $14.14B | $13.23B | $9.56B | $8.13B | $4.82B | -- | $3.84B | -- |
| Property, Plant & Equipment, Net | $1.52B | $1.23B | $1.16B | $1.11B | $1.09B | $958.5M | $745.1M | $758.1M | $812.0M | -- |
| Goodwill | $1.09B | $1.09B | $1.09B | $1.09B | $1.00B | $1.00B | $1.00B | -- | $50.38M | -- |
| Intangible Assets | $424.2M | $825.9M | $839.9M | $603.6M | $400.0M | $400.0M | $400.0M | -- | $0 | -- |
| Long-Term Investments | $5.71B | $5.11B | $2.50B | $112.2M | -- | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $1.24B | $999.3M | $895.3M | $409.6M | $110.8M | $49.30M | $69.38M | -- | $40.73M | -- |
| **Total Non-Current Assets** | $14.44B | $12.94B | $8.59B | $4.92B | $3.87B | $3.62B | $3.50B | -- | $2.40B | -- |
| **Total Assets** | $25.64B | $22.53B | $22.73B | $18.15B | $13.43B | $11.75B | $8.32B | $6.26B | $6.25B | $3.56B |
| Accounts Payable | $461.7M | $413.0M | $364.9M | $303.9M | $195.0M | $155.1M | $87.61M | -- | $111.0M | -- |
| Short-Term Debt | $0 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Current Liabilities | $428.3M | $363.0M | $527.2M | $311.5M | $268.4M | $317.4M | $130.3M | -- | $50.41M | $36.46M |
| **Total Current Liabilities** | $3.86B | $3.56B | $3.55B | $2.74B | $2.14B | $1.88B | $1.33B | -- | $1.12B | -- |
| Long-Term Debt | $0 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Non-Current Liabilities | $1.27B | $1.01B | $877.7M | $685.8M | $303.3M | $108.4M | $99.03M | $70.23M | $108.9M | -- |
| **Total Non-Current Liabilities** | $3.12B | $2.56B | $1.60B | $1.50B | $1.19B | $1.19B | $898.4M | -- | $690.4M | -- |
| **Total Liabilities** | $6.98B | $6.12B | $5.15B | $4.24B | $3.33B | $3.06B | $2.23B | -- | $1.81B | -- |
| **Total Debt (incl. Leases)** | $2.04B | $1.75B | $808.4M | $899.7M | $967.4M | $942.5M | $673.2M | $634.3M | $596.6M | -- |
| Common Stock | $2.50M | $2.60M | $2.60M | $2.60M | $2.50M | $2.60M | $2.59M | -- | $2.55M | -- |
| Retained Earnings | $13.56B | $9.61B | $10.14B | $6.52B | $3.20B | $858.7M | -$1.85B | -$3.03B | -$2.99B | -$5.11B |
| Accumulated Other Comp. Income | -$15.90M | $127.8M | -$14.30M | $800K | $15.90M | -$68.50M | -$1.97M | -- | $659K | -$10.62M |
| **Total Stockholders' Equity** | $18.67B | $16.41B | $17.58B | $13.91B | $10.10B | $8.69B | $6.09B | -- | $4.44B | -- |
| Total Equity | $18.67B | $16.41B | $17.58B | $13.91B | $10.10B | $8.69B | $6.09B | -- | $4.44B | -- |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.98B | $6.14B | $5.49B | $5.08B | $4.94B | $4.97B | $4.67B | $4.57B |
| Short-Term Investments | $1.32B | $1.71B | $1.75B | $1.52B | $1.35B | $1.41B | $1.53B | $1.55B |
| **Cash & Short-Term Investments** | $6.30B | $7.85B | $7.25B | $6.61B | $6.29B | $6.38B | $6.20B | $6.12B |
| Accounts Receivable, Net | $2.31B | $2.13B | $2.00B | $2.05B | $1.95B | $1.89B | $1.81B | $1.61B |
| Inventory | $2.25B | $1.77B | $1.77B | $1.69B | $1.63B | $1.50B | $1.36B | $1.21B |
| Other Current Assets | -- | -- | -- | $110.9M | -- | -- | -- | $76.40M |
| **Total Current Assets** | $11.69B | $12.54B | $11.73B | $11.20B | $10.57B | $10.43B | $10.01B | $9.60B |
| Property, Plant & Equipment, Net | $1.71B | $1.67B | $1.61B | $1.52B | $1.43B | $1.34B | $1.30B | $1.23B |
| Goodwill | $2.42B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B |
| Intangible Assets | $8.52B | $412.8M | $418.5M | $424.2M | $429.8M | $435.5M | $441.2M | $825.9M |
| Long-Term Investments | $3.52B | $5.79B | $5.75B | $5.71B | $5.72B | $5.65B | $5.16B | $5.11B |
| Other Non-Current Assets | $1.31B | $1.25B | $1.26B | $1.24B | $1.10B | $1.08B | $1.01B | $999.3M |
| **Total Non-Current Assets** | $21.05B | $14.88B | $14.75B | $14.44B | $14.29B | $13.61B | $12.87B | $12.94B |
| **Total Assets** | $32.74B | $27.42B | $26.48B | $25.64B | $24.86B | $24.04B | $22.88B | $22.53B |
| Accounts Payable | $472.6M | $429.5M | $489.3M | $461.7M | $420.3M | $442.3M | $445.0M | $413.0M |
| Short-Term Debt | $999.6M | -- | -- | $0 | -- | -- | -- | -- |
| Other Current Liabilities | $293.0M | $329.4M | $407.1M | $428.3M | $441.5M | $425.4M | $386.4M | $363.0M |
| **Total Current Liabilities** | $5.00B | $3.94B | $3.88B | $3.86B | $4.48B | $4.14B | $3.78B | $3.56B |
| Long-Term Debt | $3.50B | -- | -- | $0 | -- | -- | -- | -- |
| Other Non-Current Liabilities | $1.35B | $1.26B | $1.26B | $1.27B | $1.23B | $1.20B | $951.9M | $1.01B |
| **Total Non-Current Liabilities** | $6.83B | $3.24B | $3.24B | $3.12B | $3.07B | $2.72B | $2.60B | $2.56B |
| **Total Liabilities** | $11.83B | $7.18B | $7.12B | $6.98B | $7.54B | $6.86B | $6.38B | $6.12B |
| **Total Debt (incl. Leases)** | $6.48B | $1.98B | $1.99B | $2.04B | $1.83B | $1.53B | $1.65B | $1.75B |
| Common Stock | $2.50M | $2.50M | $2.50M | $2.50M | $2.50M | $2.60M | $2.60M | $2.60M |
| Retained Earnings | $16.34B | $15.69B | $14.59B | $13.56B | $12.37B | $11.29B | $10.25B | $9.61B |
| Accumulated Other Comp. Income | $57.20M | $48.50M | $24.80M | -$15.90M | -$64.50M | -$101.1M | $68.10M | $127.8M |
| **Total Stockholders' Equity** | $20.91B | $20.25B | $19.36B | $18.67B | $17.32B | $17.18B | $16.50B | $16.41B |
| Total Equity | $20.91B | $20.25B | $19.36B | $18.67B | $17.32B | $17.18B | $16.50B | $16.41B |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $3.95B | -$535.6M | $3.62B | $3.32B | $2.34B | $2.71B | $1.18B | $2.09B | $91.64M | -$84.03M |
| Depreciation & Amortization | $209.8M | $207.2M | $181.3M | $148.3M | $125.6M | $109.5M | $106.9M | $72.42M | $61.40M | $61.40M |
| Stock-Based Compensation | $685.9M | $698.5M | $581.2M | $491.3M | $441.4M | $429.5M | $360.5M | $325.0M | $293.2M | $240.6M |
| Change in Receivables | -$347.3M | -$99.30M | -$84.10M | -$358.6M | -$274.7M | -$223.4M | -$225.6M | -$108.2M | -$71.76M | -$39.09M |
| Change in Inventory | -$524.2M | -$517.3M | -$322.9M | -$136.4M | -$92.80M | -$132.0M | -$64.00M | -$31.96M | -$47.48M | -$19.37M |
| Change in Payables | $36.80M | $49.50M | $48.70M | $120.8M | $31.90M | $51.30M | -$22.80M | $36.55M | $8.75M | -$11.74M |
| **Operating Cash Flow** | $3.63B | -$492.6M | $3.54B | $4.13B | $2.64B | $3.25B | $1.57B | $1.27B | $844.9M | $236.1M |
| Capital Expenditure | -$437.6M | -$297.7M | -$200.4M | -$204.7M | -$235.0M | -$259.8M | -$75.40M | -$95.45M | -$99.42M | -$56.56M |
| **Free Cash Flow** | $3.19B | -$790.3M | $3.34B | $3.93B | $2.41B | $2.99B | $1.49B | $1.17B | $745.5M | $179.5M |
| Acquisitions, Net | -- | $0 | $0 | -$295.9M | $0 | $0 | -$1.15B | $0 | $0 | -- |
| Purchases of Investments | -$6.40B | -$7.44B | -$3.79B | -$692.7M | -$528.2M | -$431.4M | -$537.2M | -$431.9M | -- | -- |
| Sales & Maturities of Investments | -- | -- | -- | -- | -- | -- | $475.9M | -- | -- | -- |
| **Investing Cash Flow** | -$945.4M | -$3.77B | -$3.14B | -$321.1M | -$340.9M | $99.40M | -$1.24B | -$202.2M | -$483.3M | $51.24M |
| Share Repurchases | -$2.02B | -$1.18B | -$427.6M | $0 | -$1.43B | -$539.1M | -$186.0M | -$350.0M | $0 | $0 |
| **Financing Cash Flow** | -$2.26B | -$1.49B | -$562.2M | -$67.70M | -$1.48B | -$505.3M | $126.8M | -$71.22M | $68.40M | $133.3M |
| **Net Change in Cash** | $515.6M | -$5.80B | -$139.7M | $3.71B | $811.2M | $2.87B | $462.4M | $990.7M | $435.8M | $415.9M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $653.6M | $1.10B | $1.03B | $1.19B | $1.08B | $1.03B | $646.3M | $913.0M |
| Depreciation & Amortization | $69.20M | $56.50M | $55.90M | $55.70M | $54.00M | $51.70M | $48.40M | $46.50M |
| Stock-Based Compensation | $174.4M | $170.2M | $166.4M | $157.6M | $194.9M | $167.3M | $166.1M | $167.8M |
| Change in Receivables | -$173.8M | -$140.2M | $39.80M | -$99.40M | -$59.90M | -$18.40M | -$169.6M | $69.00M |
| Change in Inventory | -$34.20M | -$27.70M | -$97.70M | -$77.40M | -$131.1M | -$148.6M | -$167.1M | -$147.5M |
| Change in Payables | $40.90M | -$66.70M | $35.60M | $38.30M | -$35.30M | $7.60M | $26.20M | $8.40M |
| **Operating Cash Flow** | $643.1M | $1.13B | $1.43B | $498.0M | $1.24B | $1.07B | $818.9M | $584.6M |
| Capital Expenditure | -$97.30M | -$112.2M | -$133.4M | -$149.4M | -$101.8M | -$145.7M | -$40.70M | -$92.60M |
| **Free Cash Flow** | $545.8M | $1.01B | $1.29B | $348.6M | $1.14B | $927.4M | $778.2M | $492.0M |
| Purchases of Investments | -$1.10B | -$2.36B | -$2.51B | -$1.23B | -$1.35B | -$2.17B | -$1.65B | -$2.16B |
| **Investing Cash Flow** | -$6.10B | -$45.80M | -$431.9M | -$288.1M | -$117.0M | -$484.5M | -$55.80M | -$821.9M |
| Share Repurchases | -$126.7M | -$469.5M | -$336.9M | -$128.4M | -$1.07B | -$391.8M | -$426.1M | -$417.9M |
| **Financing Cash Flow** | $4.30B | -$426.7M | -$538.8M | -$77.20M | -$1.15B | -$349.2M | -$680.4M | -$391.3M |
| **Net Change in Cash** | -$1.17B | $649.2M | $417.1M | $140.0M | -$34.20M | $296.6M | $113.2M | -$675.9M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 86.2% | 86.1% | 87.2% | 87.9% | 88.1% | 88.1% | 86.8% | 86.6% | 88.9% | 87.6% |
| **Operating Margin** | 34.8% | -2.1% | 38.8% | 48.2% | 36.7% | 46.0% | 28.8% | 20.8% | 5.0% | 0.6% |
| **Net Profit Margin** | 32.9% | -4.9% | 36.7% | 37.2% | 30.9% | 43.7% | 28.3% | 68.8% | 10.6% | -6.6% |
| Return on Equity (ROE) | 21.2% | -3.3% | 20.6% | 23.9% | 23.2% | 31.2% | 19.3% | 47.3% | 13.0% | -9.7% |
| Return on Assets (ROA) | 15.4% | -2.4% | 15.9% | 18.3% | 17.4% | 23.1% | 14.1% | 33.6% | 7.4% | -3.9% |
| Current Ratio | 2.90x | 2.69x | 3.99x | 4.83x | 4.46x | 4.33x | 3.61x | 3.43x | 3.28x | 2.31x |
| Quick Ratio | 2.46x | 2.35x | 3.78x | 4.66x | 4.30x | 4.18x | 3.49x | 3.32x | 3.14x | 2.21x |
| Debt to Equity | 0.11x | 0.11x | 0.05x | 0.06x | 0.10x | 0.11x | 0.11x | 0.13x | -- | -- |
| **Revenue Growth (YoY)** | +8.9% | +11.7% | +10.5% | +17.9% | +22.1% | +49.1% | +36.6% | +22.5% | +46.2% | +64.9% |
| Gross Profit Growth (YoY) | +9.1% | +10.3% | +9.6% | +17.7% | +22.0% | +51.3% | +37.0% | +19.2% | +48.4% | +63.0% |
| Operating Income Growth (YoY) | -- | -106.1% | -11.0% | +54.8% | -2.6% | +138.5% | +88.5% | +415.4% | +1140.4% | -- |
| **Net Income Growth (YoY)** | -- | -114.8% | +9.0% | +41.8% | -13.6% | +130.4% | -43.9% | +695.8% | -- | -- |
| EPS Growth (YoY) | -- | -114.8% | +8.3% | +42.7% | -12.9% | +127.9% | -44.4% | +677.4% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -113.9% | -14.3% | +56.2% | -18.7% | +107.3% | +23.5% | +50.3% | +257.9% | -- |
| Free Cash Flow Growth (YoY) | -- | -123.7% | -15.0% | +63.0% | -19.5% | +100.4% | +27.2% | +57.6% | +315.2% | -- |
| 5Y Revenue / Share Growth | +96.5% | +163.5% | +219.6% | +248.7% | +322.5% | +458.4% | +557.4% | +122.4% | +38.8% | +1.0% |
| 10Y Revenue / Share Growth | +997.1% | +1632.3% | +610.7% | +384.0% | +326.9% | +3238.8% | +2657.6% | +859.8% | -- | -- |
| 5Y Net Income / Share Growth | +48.1% | -145.3% | +70.3% | +1125.1% | -- | -- | -- | -- | -- | -417.3% |
| 10Y Net Income / Share Growth | -- | -- | -- | -- | +6196.6% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 85.5% | 86.0% | 86.2% | 86.2% | 86.3% | 86.1% | 86.0% | 86.1% |
| **Operating Margin** | 33.2% | 38.0% | 38.3% | 34.8% | 34.1% | 34.4% | -6.7% | -2.1% |
| **Net Profit Margin** | 30.7% | 35.0% | 35.5% | 32.9% | 31.3% | 31.9% | -8.9% | -4.9% |
| Return on Equity (ROE) | 19.0% | 21.8% | 22.4% | 21.2% | 21.2% | 21.2% | -6.0% | -3.3% |
| Return on Assets (ROA) | 12.1% | 16.1% | 16.4% | 15.4% | 14.8% | 15.1% | -4.3% | -2.4% |
| Current Ratio | 2.34x | 3.19x | 3.02x | 2.90x | 2.36x | 2.52x | 2.65x | 2.69x |
| Quick Ratio | 1.89x | 2.74x | 2.57x | 2.46x | 2.00x | 2.16x | 2.29x | 2.35x |
| Debt to Equity | 0.31x | 0.10x | 0.10x | 0.11x | 0.11x | 0.09x | 0.10x | 0.11x |
| **Revenue Growth (YoY)** | +11.8% | +12.5% | +7.8% | +9.5% | +11.0% | +12.1% | +3.0% | +15.7% |
| Gross Profit Growth (YoY) | +9.5% | +11.2% | +7.8% | +9.5% | +11.9% | +12.5% | +2.5% | +15.8% |
| Operating Income Growth (YoY) | -39.9% | +8.3% | +80.6% | +17.5% | +6.3% | -- | -44.7% | +3.8% |
| **Net Income Growth (YoY)** | -39.6% | +6.5% | +59.6% | +30.5% | +3.6% | -- | -41.2% | -5.8% |
| EPS Growth (YoY) | -39.2% | +8.0% | +61.1% | -- | +4.7% | -- | -40.8% | -- |
| Operating Cash Flow Growth (YoY) | -48.2% | +4.9% | +74.4% | -14.8% | -9.4% | -- | -37.3% | +149.2% |
| Free Cash Flow Growth (YoY) | -52.1% | +9.3% | +66.4% | -29.1% | -12.5% | -- | -37.2% | +178.8% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
